Does SATRALIZUMAB-MWGE Cause Hypoaesthesia? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Hypoaesthesia have been filed in association with SATRALIZUMAB-MWGE. This represents 2.7% of all adverse event reports for SATRALIZUMAB-MWGE.
30
Reports of Hypoaesthesia with SATRALIZUMAB-MWGE
2.7%
of all SATRALIZUMAB-MWGE reports
0
Deaths
11
Hospitalizations
How Dangerous Is Hypoaesthesia From SATRALIZUMAB-MWGE?
Of the 30 reports, 11 (36.7%) required hospitalization.
Is Hypoaesthesia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SATRALIZUMAB-MWGE. However, 30 reports have been filed with the FAERS database.
What Other Side Effects Does SATRALIZUMAB-MWGE Cause?
Neuromyelitis optica spectrum disorder (181)
Off label use (87)
Urinary tract infection (87)
Pneumonia (64)
Covid-19 (47)
No adverse event (47)
Fatigue (41)
Headache (36)
Pain (36)
Arthralgia (31)
What Other Drugs Cause Hypoaesthesia?
ADALIMUMAB (7,423)
ETANERCEPT (4,497)
METHOTREXATE (4,175)
RITUXIMAB (3,605)
TOFACITINIB (3,324)
PREDNISONE (3,239)
TOCILIZUMAB (3,238)
FINGOLIMOD (3,180)
LENALIDOMIDE (3,127)
SECUKINUMAB (3,079)
Which SATRALIZUMAB-MWGE Alternatives Have Lower Hypoaesthesia Risk?
SATRALIZUMAB-MWGE vs SAXAGLIPTIN
SATRALIZUMAB-MWGE vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SATRALIZUMAB-MWGE vs SCOPOLAMINE
SATRALIZUMAB-MWGE vs SCOPOLAMINE HYDROBROMIDE
SATRALIZUMAB-MWGE vs SEBELIPASE ALFA